½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting



»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹BCL7A¶à¿Ë¡¿¹Ìå

²úÆ·ÖÐÐÄ

×îвúÆ·

  • Íÿ¹BCL7A¶à¿Ë¡¿¹Ìå

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW3311
    • Ó¦Óà : ½öÓÃÓÚ¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º100ul/200ul/25ul
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·

ÖÐÎÄÃû³Æ£º Íÿ¹BCL7A¶à¿Ë¡¿¹Ìå

Ó¢ÎÄÃû³Æ£º Anti-BCL7A rabbit polyclonal antibody

±ð      Ãû£º BCL7

Ïà¹ØÀà±ð£º Ò»¿¹

´¢      ´æ£º Àä¶³£¨-20¡æ£© ±Ü¹â

ËÞ      Ö÷£º Rabbit

¿¹      Ô­£º BCL7A

·´Ó¦ÖÖÊô£º Human

±ê ¼Ç Î Unconjugate

¿Ë¡ÀàÐÍ£º Unconjugate

¼¼Êõ¹æ¸ñ

Background:

This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene.

Applications:

WB

Name of antibody:

BCL7A

Immunogen:

Synthesized peptide derived from internal of human BCL7A.

Full name:

B-cell CLL/lymphoma 7A

Synonyms£º

BCL7

SwissProt:

Q4VC05

WB Predicted band size:

23 kDa

WB Positive control:

Huvec cells lysate

WB Recommended dilution:

500-3000






¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿